Loading…
← CockpitCompetitor Analysis › APOLLOHOSP.NS Apollo Hospitals EnterpriseOpen in the cockpit ↗

Apollo Hospitals EnterpriseAPOLLOHOSP.NSCompetitor analysis, valuation and peers

India · INR·Pharma & Healthcare›Hospital/Nursing Management

India's largest private hospital chain, also running pharmacies and a digital-health platform.

≈ India's HCA Healthcare plus a CVS-style pharmacy armMomentum strong 72
Mkt cap
$13.6B
US dollars, full cap
Free float
68%
of shares outstanding
$/day
$45.8M
20-day average traded
Fwd P/E
51.0×
forward earnings
ROIC−WACC
+2.6 pp
WACC 11.7%
Hurdle
+14 pp
Req g minus delivered
Next earnings
79 days
5 Feb 2027
Close · INR₹8,821
1D+1.2%
1W+2.5%
1M+14.6%
3M+0.1%
6M+9.9%
YTD+25.2%
1Y+17.6%
ATR %2.2%
Beta0.51
52w lowhigh2.8% off high

What Apollo Hospitals Enterprise does

India's largest private hospital chain, also running pharmacies and a digital-health platform.

Hospitals earn most of the profit through bed occupancy, fees per patient and the mix of complex procedures. Pharmacy retail and the digital arm bring in a large share of sales but at much lower margins. Apollo was founded in 1983 as India's first corporate hospital chain.

In one line: India's HCA Healthcare plus a CVS-style pharmacy arm.

Products and services

  • Hospital / tertiary care services
  • Pharmacy retail (Apollo Pharmacy)
  • Digital health & diagnostics (Apollo 24|7)
  • Health insurance distribution

Customers

  • Domestic patients across income tiers
  • Medical tourists
  • Corporate/insurance-covered patients

Where it sits in the supply chain

  • Private healthcare delivery
  • Hospitals, pharmacy retail, digital…
  • Tertiary-care hospitals, Apollo…

What could go right

  • Rising Indian private healthcare/insurance penetration
  • Medical tourism demand

What could go wrong

  • Capital-intensive hospital bed expansion
  • Regulatory price caps on procedures/drugs

Moat: narrow (brand, scale, installed base). Strongest brand and largest bed/pharmacy network in Indian private healthcare builds patient and doctor trust.

Headquarters: Chennai, India · Founded: 1983 · Employees: 44,008

Named competitors

Apollo Hospitals Enterprise at a glance

Size Apollo Hospitals Enterprise (APOLLOHOSP.NS) is an India Health Care company (Hospital/Nursing Management) with a market value of $13.6B, the 79th largest of 1,066 India companies the cockpit tracks. Shares closed at ₹8,821 on 18 Nov 2026.

Performance Over six months the shares gained 9.9%, against +15.8% for the median peer and +3.8% for the India market (cap-weighted) — 6th lowest of 14 in its peer set.

Growth Revenue grew 19.2% over the last twelve months (peer median +13.1%); the operating margin is 12.1% (peer median 13.4%).

Valuation It trades at 51.0× forward earnings against a peer median of 41.3× (6th most expensive of 15).

Price implies For today's price to make sense, revenue must grow about 33% a year for seven years (Req g). Recent delivered growth is +19%, so the hurdle is +14 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.

Capital Return on invested capital runs 2.6 points above its cost of capital (11.7% WACC).

Next results Next results expected around 5 Feb 2027 (exchange calendar; dates can move).

Relative performance

10011012021 May 202621 Aug 202618 Nov 2026Peer median 116APOLLOHOSP.NS 109
Six months, rebased to 100: Apollo Hospitals Enterprise against the median of its 14 peers (local-currency closes).

Apollo Hospitals Enterprise financials

Reported figures in INR; fiscal year ends 2026-03-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue₹277B₹252B₹218B₹191B₹166B
Revenue growth—+16%+14%+15%—
Gross profit₹93.1B₹47.7B₹40.2B₹34.9B₹29.9B
EBITDA₹42.6B₹38.1B₹30.6B₹24.1B₹20.8B
Net income₹22.4B₹19.4B₹14.5B₹8.99B₹8.19B
Free cash flown/a₹7.12B₹2.16B₹5.20B₹461M
Capital expendituren/a₹19.6B₹17.1B₹11.4B₹11.3B
Total debt₹81.5B₹84.9B₹78.6B₹53.3B₹43.3B

Quarterly statements and history in the cockpit →

Apollo Hospitals Enterprise competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

0%+50%+100%0%+25%+50%+75%UHSMAXHEALTHTHCRHCPACSCHEASTERDMFORTISFRENHMEDANTASGRYKIMSAPOLLOHOSP.NS6-month return →1-month return →
Up and to the right = strong over both horizons. Apollo Hospitals Enterprise is the large dot.

Fundamentals: revenue growth against valuation

0%+20%+40%+60%25×50×75×UHSMAXHEALTHMANIPALHOSTHCRHCPACSASTERDMFORTISNHMEDANTASGRYKIMSAPOLLOHOSP.NSRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Apollo Hospitals Enterprise is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%0%20%40%UHSMAXHEALTHMANIPALHOSTHCRHCPACSCHEASTERDMFORTISFRENHSGRYAPOLLOHOSP.NSGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Apollo Hospitals Enterprise is the large dot.

Apollo Hospitals Enterprise competitors and peer comparison

Head to head with its named competitors (APOLLOHOSP.NS vs MAXHEALTH.NS vs MANIPALHOS.NS vs FORTIS.NS)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Apollo Hospitals Enterprise APOLLOHOSP.NS$13.6B+10%+19%12%51.0×33.3%
Max Healthcare Institute MAXHEALTH.NS$10.6B-4%+15%21%55.2×45.3%
Manipal Health Enterprises MANIPALHOS.NS$9.69Bn/a+25%19%66.5×32.9%
Fortis Healthcare FORTIS.NS$6.40B-17%+18%17%48.5×42.5%
Narayana Hrudayalaya NH.NS$4.13B0%+71%13%34.2×31.2%

How Apollo Hospitals Enterprise compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Apollo Hospitals Enterprise against its 14 peers (data as of 18 Nov 2026)
MeasureAPOLLOHOSP.NSPeer medianRank in peer set
1-month return+14.6%+9.0%5th highest of 15
6-month return+9.9%+15.8%6th lowest of 14
Distance from 52-week high-2.8%-10.2%3rd highest of 15
Revenue growth (TTM)+19.2%+13.1%6th highest of 15
Operating margin12.1%13.4%6th lowest of 15
Forward P/E51.0×41.3×6th most expensive of 15
Growth the price implies (Req g, 7 yrs)33.3%14.8%4th most demanding of 13
Growth delivered (Del g)+19.0%+10.3%5th highest of 13
Hurdle (Req g minus delivered)+14.3 pp+4.9 pp5th most demanding of 13
ROIC minus cost of capital+2.6 pp-1.6 pp4th highest of 15
EV / EBITDA31.2×21.6×6th most expensive of 15
Net debt / EBITDA1.4×2.2×6th least indebted of 15

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Apollo Hospitals Enterprise APOLLOHOSP.NSIndia$13.6B+10%+19%12%51.0×33.3%+19.0%
Universal Health Services UHSUnited States$10.7B+13%+8%11%8.3×-1.8%+8.5%
Max Healthcare Institute MAXHEALTH.NSIndia$10.6B-4%+15%21%55.2×45.3%+27.2%
Manipal Health Enterprises MANIPALHOS.NSIndia$9.69Bn/a+25%19%66.5×32.9%+28.8%
Tenet Healthcare THCUnited States$21.6B+45%+6%17%13.4×-1.4%+3.9%
Ramsay Health Care RHC.AXAustralia$8.31B+41%+4%5%31.4×14.0%+8.3%
PACS PACSUnited States$7.35B+25%+11%8%17.5×7.5%+29.7%
Chemed CHEUnited States$7.12B+24%+5%14%20.2×3.3%+4.0%
Aster DM Quality Care ASTERDM.NSIndia$6.83B-2%+50%16%63.5×48.6%-11.6%
Fortis Healthcare FORTIS.NSIndia$6.40B-17%+18%17%48.5×42.5%+17.9%
Fresenius SE & Co. KGaA FRE.DEGermany$32.7B+41%+7%10%14.7×7.0%-8.8%
Narayana Hrudayalaya NH.NSIndia$4.13B0%+71%13%34.2×31.2%+25.0%
Global Health MEDANTA.NSIndia$4.13B+16%+26%17%50.4×n/an/a
Surgery Partners SGRYUnited States$3.53B+100%+2%13%77.2×15.6%+12.2%
Krishna Institute of Medical Sciences KIMS.NSIndia$3.41B+2%+35%11%81.9×n/an/a

Questions

Who are Apollo Hospitals Enterprise's main competitors?
Named competitors: Max Healthcare Institute (MAXHEALTH.NS), Manipal Health Enterprises (MANIPALHOS.NS), Fortis Healthcare (FORTIS.NS), Narayana Hrudayalaya (NH.NS). The cockpit's measured peer set (industry) also includes Universal Health Services (UHS), Max Healthcare Institute (MAXHEALTH.NS), Manipal Health Enterprises (MANIPALHOS.NS), Tenet Healthcare (THC), Ramsay Health Care (RHC.AX), PACS (PACS).
Is Apollo Hospitals Enterprise expensive compared with its peers?
On forward p/e it trades at 51.0× against a peer median of 41.3×, 6th most expensive of 15 in its peer set. For today's price to make sense, revenue must grow about 33% a year for seven years (Req g). Recent delivered growth is +19%, so the hurdle is +14 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
How has Apollo Hospitals Enterprise stock performed?
Over six months to 18 Nov 2026 the shares returned +9.9% against +15.8% for the median peer; over one year +17.6%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.